Atherosclerosis coronary artery disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria 1. Written and signed informed consent. 2. Male or female patients. 3. Scheduled for elective CABG. 4. >= 50% stenosis of the RCA, LAD, diagonal branche of the LAD (DIAG) or mo branches of the RCx.
Exclusion criteria
Exclusion criteria: Exclusion criteria 1. Thyroid disease (TSH 5.0 mU/L or use of thyroid hormones) 2. History of malignancy (in the last 2 years) 3. Use of thiazolidinediones 4. Use of immune suppressive medication (equivalent of prednisolon >= 10 mg /day) 5. Renal failure GFR
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| onderzoeksvariabelen: - Adipokine en cytokine mRNA expression (RT-PCR) and secretion (Western blotting): adiponectin, IL-6, TNF-a, resistin, PAI-1 en visfatin - Histologic parameters of inflammation: macrophage infiltration (macrophages per view), capillary injection (capillaries per view) en fat necrosis (presence of) . outcome measures: - Stenosis (atherosclerotic plaque) measured with coronary angiography. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Plasma adipokine and cytokine concentrations (adiponectine, IL-6, TNF-a, resistin, PAI-1 en visfatin) - Parameters of the metabolic syndrome (waist circumference (cm), LDL-c, HDL-c, total cholesterol, fasting glucose, blood pressure) - Adipocyte size | — |
Countries
Netherlands